Aspira Women's Health Inc. (AWH)
USD 0.1
(0.93%)
USD 0.1
(0.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.62 Million USD | -18.93% |
| 2022 | 10.64 Million USD | -2.43% |
| 2021 | 10.9 Million USD | 10.33% |
| 2020 | 9.88 Million USD | 94.22% |
| 2019 | 5.09 Million USD | 19.6% |
| 2018 | 4.25 Million USD | 4.06% |
| 2017 | 4.09 Million USD | -3.92% |
| 2016 | 4.25 Million USD | 24.69% |
| 2015 | 3.41 Million USD | -30.6% |
| 2014 | 4.91 Million USD | 26.97% |
| 2013 | 3.87 Million USD | -2.34% |
| 2012 | 3.96 Million USD | -68.89% |
| 2011 | 12.75 Million USD | -34.33% |
| 2010 | 19.41 Million USD | -39.17% |
| 2009 | 31.92 Million USD | -3.04% |
| 2008 | 32.92 Million USD | -7.29% |
| 2007 | 35.51 Million USD | 7.89% |
| 2006 | 32.91 Million USD | -28.89% |
| 2005 | 46.28 Million USD | -2.88% |
| 2004 | 47.66 Million USD | -11.69% |
| 2003 | 53.96 Million USD | 180.66% |
| 2002 | 19.22 Million USD | 41.52% |
| 2001 | 13.58 Million USD | 134.42% |
| 2000 | 5.79 Million USD | 41.78% |
| 1999 | 4.08 Million USD | -85.09% |
| 1998 | 27.41 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8.52 Million USD | -1.16% |
| 2024 Q2 | 7.67 Million USD | -10.05% |
| 2023 Q1 | 10.66 Million USD | 0.25% |
| 2023 Q2 | 8.24 Million USD | -22.69% |
| 2023 Q3 | 9.32 Million USD | 13.01% |
| 2023 Q4 | 8.62 Million USD | -7.45% |
| 2023 FY | 8.62 Million USD | -18.93% |
| 2022 Q4 | 10.64 Million USD | -16.62% |
| 2022 FY | 10.64 Million USD | -2.43% |
| 2022 Q2 | 9.89 Million USD | 8.52% |
| 2022 Q1 | 9.11 Million USD | -16.41% |
| 2022 Q3 | 12.76 Million USD | 29.01% |
| 2021 Q3 | 9.54 Million USD | 6.14% |
| 2021 Q4 | 10.9 Million USD | 14.29% |
| 2021 FY | 10.9 Million USD | 10.33% |
| 2021 Q1 | 9.97 Million USD | 0.87% |
| 2021 Q2 | 8.99 Million USD | -9.84% |
| 2020 FY | 9.88 Million USD | 94.22% |
| 2020 Q1 | 5.05 Million USD | -0.77% |
| 2020 Q2 | 5.82 Million USD | 15.3% |
| 2020 Q3 | 6.71 Million USD | 15.3% |
| 2020 Q4 | 9.88 Million USD | 47.22% |
| 2019 FY | 5.09 Million USD | 19.6% |
| 2019 Q2 | 4.78 Million USD | 3.66% |
| 2019 Q1 | 4.61 Million USD | 8.48% |
| 2019 Q3 | 4.7 Million USD | -1.67% |
| 2019 Q4 | 5.09 Million USD | 8.16% |
| 2018 Q4 | 4.25 Million USD | 13.07% |
| 2018 Q1 | 4.2 Million USD | 2.89% |
| 2018 Q2 | 4.05 Million USD | -3.68% |
| 2018 FY | 4.25 Million USD | 4.06% |
| 2018 Q3 | 3.76 Million USD | -7.13% |
| 2017 Q3 | 3.75 Million USD | 3.04% |
| 2017 Q2 | 3.64 Million USD | -6.58% |
| 2017 FY | 4.09 Million USD | -3.92% |
| 2017 Q4 | 4.09 Million USD | 8.86% |
| 2017 Q1 | 3.9 Million USD | -8.32% |
| 2016 FY | 4.25 Million USD | 24.69% |
| 2016 Q1 | 2.99 Million USD | -12.27% |
| 2016 Q2 | 4.39 Million USD | 46.71% |
| 2016 Q3 | 4.39 Million USD | -0.05% |
| 2016 Q4 | 4.25 Million USD | -3.07% |
| 2015 Q4 | 3.41 Million USD | 4.31% |
| 2015 FY | 3.41 Million USD | -30.6% |
| 2015 Q3 | 3.27 Million USD | 5.11% |
| 2015 Q2 | 3.11 Million USD | -10.65% |
| 2015 Q1 | 3.48 Million USD | -29.15% |
| 2014 Q1 | 4.34 Million USD | 12.24% |
| 2014 Q3 | 5.83 Million USD | 1.09% |
| 2014 FY | 4.91 Million USD | 26.97% |
| 2014 Q2 | 5.76 Million USD | 32.68% |
| 2014 Q4 | 4.91 Million USD | -15.66% |
| 2013 Q2 | 4.39 Million USD | 3.85% |
| 2013 Q3 | 4.83 Million USD | 10.18% |
| 2013 Q4 | 3.87 Million USD | -19.94% |
| 2013 FY | 3.87 Million USD | -2.34% |
| 2013 Q1 | 4.22 Million USD | 6.6% |
| 2012 Q3 | 11.49 Million USD | -2.24% |
| 2012 Q2 | 11.75 Million USD | -0.52% |
| 2012 Q1 | 11.81 Million USD | -7.35% |
| 2012 Q4 | 3.96 Million USD | -65.47% |
| 2012 FY | 3.96 Million USD | -68.89% |
| 2011 FY | 12.75 Million USD | -34.33% |
| 2011 Q1 | 19.14 Million USD | -1.42% |
| 2011 Q3 | 14.87 Million USD | -24.49% |
| 2011 Q4 | 12.75 Million USD | -14.25% |
| 2011 Q2 | 19.69 Million USD | 2.88% |
| 2010 Q2 | 24.6 Million USD | -25.94% |
| 2010 FY | 19.41 Million USD | -39.17% |
| 2010 Q1 | 33.22 Million USD | 4.06% |
| 2010 Q4 | 19.41 Million USD | -11.28% |
| 2010 Q3 | 21.88 Million USD | -11.04% |
| 2009 Q4 | 31.92 Million USD | -26.64% |
| 2009 Q1 | 33.8 Million USD | 2.66% |
| 2009 FY | 31.92 Million USD | -3.04% |
| 2009 Q3 | 43.52 Million USD | 24.61% |
| 2009 Q2 | 34.92 Million USD | 3.32% |
| 2008 Q3 | 32.01 Million USD | -3.46% |
| 2008 FY | 32.92 Million USD | -7.29% |
| 2008 Q1 | 34.11 Million USD | -3.96% |
| 2008 Q2 | 33.16 Million USD | -2.78% |
| 2008 Q4 | 32.92 Million USD | 2.85% |
| 2007 FY | 35.51 Million USD | 7.89% |
| 2007 Q1 | 34.04 Million USD | 3.42% |
| 2007 Q2 | 35.4 Million USD | 4.01% |
| 2007 Q3 | 34.95 Million USD | -1.27% |
| 2007 Q4 | 35.51 Million USD | 1.59% |
| 2006 Q3 | 46.76 Million USD | 0.62% |
| 2006 FY | 32.91 Million USD | -28.89% |
| 2006 Q1 | 45.19 Million USD | -2.37% |
| 2006 Q2 | 46.47 Million USD | 2.85% |
| 2006 Q4 | 32.91 Million USD | -29.61% |
| 2005 Q2 | 45.22 Million USD | 0.8% |
| 2005 Q1 | 44.85 Million USD | -5.88% |
| 2005 Q3 | 43.87 Million USD | -2.97% |
| 2005 Q4 | 46.28 Million USD | 5.5% |
| 2005 FY | 46.28 Million USD | -2.88% |
| 2004 Q2 | 53.15 Million USD | -1.63% |
| 2004 FY | 47.66 Million USD | -11.69% |
| 2004 Q4 | 47.66 Million USD | -6.39% |
| 2004 Q1 | 54.03 Million USD | 0.12% |
| 2004 Q3 | 50.91 Million USD | -4.22% |
| 2003 Q2 | 23.16 Million USD | 13.15% |
| 2003 Q3 | 51.28 Million USD | 121.36% |
| 2003 Q4 | 53.96 Million USD | 5.23% |
| 2003 Q1 | 20.47 Million USD | 6.48% |
| 2003 FY | 53.96 Million USD | 180.66% |
| 2002 Q3 | 17.1 Million USD | 8.2% |
| 2002 Q1 | 13.1 Million USD | -3.58% |
| 2002 FY | 19.22 Million USD | 41.52% |
| 2002 Q4 | 19.22 Million USD | 12.42% |
| 2002 Q2 | 15.8 Million USD | 20.66% |
| 2001 Q4 | 13.58 Million USD | 12.91% |
| 2001 Q3 | 12.03 Million USD | 74.15% |
| 2001 Q2 | 6.91 Million USD | 5.48% |
| 2001 FY | 13.58 Million USD | 134.42% |
| 2001 Q1 | 6.55 Million USD | 13.03% |
| 2000 Q4 | 5.79 Million USD | 6.06% |
| 2000 Q3 | 5.46 Million USD | 0.0% |
| 2000 FY | 5.79 Million USD | 41.78% |
| 1999 FY | 4.08 Million USD | -85.09% |
| 1998 FY | 27.41 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| bioAffinity Technologies, Inc. | 3.36 Million USD | -156.276% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -54.173% |
| Standard BioTools Inc. | 159.86 Million USD | 94.604% |
| Inotiv, Inc. | 588.04 Million USD | 98.533% |
| Prenetics Global Limited | 44.01 Million USD | 80.399% |
| Neuronetics, Inc. | 81.64 Million USD | 89.433% |
| Star Equity Holdings, Inc. | 21.67 Million USD | 60.198% |
| Castle Biosciences, Inc. | 86.54 Million USD | 90.031% |
| Psychemedics Corporation | 6.59 Million USD | -30.752% |
| RadNet, Inc. | 2.07 Billion USD | 99.584% |
| Exact Sciences Corporation | 3.32 Billion USD | 99.741% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 99.514% |
| iSpecimen Inc. | 6.07 Million USD | -41.937% |
| OpGen, Inc. | 13.44 Million USD | 35.829% |
| Exagen Inc. | 34.25 Million USD | 74.812% |
| Bionano Genomics, Inc. | 118.24 Million USD | 92.704% |
| CareDx, Inc | 223.28 Million USD | 96.136% |
| Check-Cap Ltd. | 1.33 Million USD | -548.647% |
| Twist Bioscience Corporation | 152.97 Million USD | 94.36% |
| Guardant Health, Inc. | 1.62 Billion USD | 99.47% |
| Biodesix, Inc. | 94.51 Million USD | 90.872% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -395.252% |
| Precipio, Inc. | 3.67 Million USD | -134.94% |
| Natera, Inc. | 691.79 Million USD | 98.753% |
| Fulgent Genetics, Inc. | 139.82 Million USD | 93.83% |
| Sera Prognostics, Inc. | 25.28 Million USD | 65.878% |
| 23andMe Holding Co. | 206.64 Million USD | 95.825% |
| OPKO Health, Inc. | 622.47 Million USD | 98.614% |
| Personalis, Inc. | 95.65 Million USD | 90.981% |
| Aclaris Therapeutics, Inc. | 40.22 Million USD | 78.554% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | 1.733% |
| T2 Biosystems, Inc. | 62.83 Million USD | 86.27% |
| Neogen Corporation | 1.44 Billion USD | 99.401% |
| Myriad Genetics, Inc. | 312.9 Million USD | 97.243% |
| ICON Public Limited Company | 7.74 Billion USD | 99.889% |
| NeoGenomics, Inc. | 739.69 Million USD | 98.834% |
| Star Equity Holdings, Inc. | 21.67 Million USD | 60.198% |
| MDxHealth SA | 121.92 Million USD | 92.924% |
| Prenetics Global Limited | 44.01 Million USD | 80.399% |
| Illumina, Inc. | 4.36 Billion USD | 99.802% |
| DarioHealth Corp. | 38.24 Million USD | 77.443% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -687.741% |
| Medpace Holdings, Inc. | 1.09 Billion USD | 99.214% |
| Mainz Biomed B.V. | 12.15 Million USD | 29.053% |
| Trinity Biotech plc | 83.38 Million USD | 89.654% |
| Sotera Health Company | 2.68 Billion USD | 99.679% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -156.276% |